The pharmaceutical world is observing a significant shift in glucose therapy with the introduction of GLP-1 skin applications. These devices offer a possibly more user-friendly alternative to shots of GLP-1 receptor agonists, lessening the frequency of daily needle pricks. The technology releases the compound directly through the surface, arguab… Read More